Summary: A quantitative gas liquid Chromatographie method for the determination of serum levels of perazine (10-[3'-(r / -methyl-4"-piperazinyl)-propyl]-phenothiazine) is described. Perazine is used as a neuroleptic drug. The main problem consists in optimizing the Chromatographie system. A sensitivity of appr. 60-150 nmol/1 (20-50 Mg/1) serum is achieved. Examples of optimization, analyses with patient samples, and the reproducibility of the results are presented. 
Introduction
The quantitative determination of perazine (10-[3 f -(1 "-methyl·4"-pipe azinyl)-propyl]-phenothiazine *) in human serum samples under clinical routine conditions presents an analytical problem which has not yet found a satisfactory solution. Therapeutic serum levels of perazine can be expected to be within the range of approx. 59-885 nmol/1 (20-300 Mg/l) (1) . Spectrophotometric and fluorometric methods are unsuitable, owing to the codeterminatipn of metabolites (2, 3) . The Chromatographie separation of serum eluates is an indispensable prelude to the detection step, but this entails a loss of material and reduced sensitivity. The autoxidability of the phenothiazines provides 1 additional analytical problems.
Breyer & Villumsen (1) have developed a direct densito. metric thin layer Chromatographie method, which has been shown to be very sensitive but also rather timeconsuming (4) . The use of gas liquid chromatography (GLC) entails some special difficulties, which are r ) Taxilan, Promonta, D-2000 Hamburg 26 described in detail below. The very sensitive electron capture detectors, which have been used for determination of phenothiazine derivatives such as chlorpromazine or perphenazine, cannot be applied in the case of perazine. For the determination of 20-50 ng perazine by use of the FID, however, the analytical procedure must be fully optimized. In the method published recently by Vanderheeren et al. (5) most of the steps are not optimized, so that determinations are^limited to samples containing from 1.47 nmol (= 100 Mg/1 serum with 5 ml serum extracted) upwards. It is, however, possible, to perform 20 GLC determinations of perazine daily per column with a lower detection limit of 59 nmol/1 (20 Mg/1), providing the following optimization procedures are taken into consideration.
Material and Methods

Material
All reagents were Merck p.a. quality. Siliconc XE 60, Silicone OV-12, dichlormethylsilane, Chromosorb G and Gaschrome Q 80/100; 100/120 mesh were ordered from WGA-Düsseldorf.
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Preparation of glass vessels
Cleaning of all glass vessels should be done without detergents. All glass vessels, after being cleaned with hot water, are boiled in about 6 mol/1 HC1, rinsed with double distilled water, dried, and treated with 50 ml/1 dichloromethane in toluene. They are dried finally at 120°C for 1 hour. 
Results and Discussion
Extraction procedure We investigated the distribution coefficients and elution characteristics of the following solvents: Methylene dichloride, chloroform, ethylene dichloride, benzene, toluene, Η-heptane, w-heptane/isoamyl alcohol (985 ml + 15 ml) in relationship to the pH of the aqueous phase (4). w-heptane was found to be the most suitable solvent for the GLC procedure: at pH 10.4 the distribution coefficient was 5.7 and the coextraction of serum factors was the lowest with regard of the temperature range used for perazine detection ( fig. 1 a) . Sufficiently low solubility of perazine base in water is achieved in an alkaline milieu, i.e. pH 8.5. Short heating of the alkalinized serum samples in a boiling water bath results in a better separation of the organic and the aqueous phase without loss of the drug (tab. 1). Inactivation of the surface of the glass vessels e.g. by silanization leads to considerably increased recovery values. The use of detergents for cleaning of the test tubes etc. must be avoided under any circumstances. Precleaning is done best by boiling with about 6 mol/1 hydrochloric acid.
Optimization of the GLC system As stationary phases we have examined silicone^XE-60 and silicone-OV-17 (3%) on Chrornosorb G or Gaschrome Q (80/100 or 100/120 mesh resp.). Resolution with the 80/100 mesh supports was lower and the loss of perazine greater than with the 100/120 mesh ab- sorbents. The most suitable stationary phase proved to be 3% silicone-OV-17 on Gaschrome Q 100/120 mesh. Optimization is achieved by determination of the Van Deemter hyperbolic function which relates the column efficiency -expressed as height equivalent to a theoretical plate (HETP) -to carrier gas flow changes; in addition, peak height, peak area and retention time were taken into consideration ( fig. 2 ). Measurements were performed with standard solutions of 2.95 mmol/1 perazine in ethanol. The aim is to find the carrier gas flow rate at minimal retention time (in order to increase the laboratory capacity) and at maximum peak height or area (in order to increase the sensitivity). From figure 2 it can be seen that it is not reasonable to make use of the highest possible separation performance (achieved at u = < 10 ml/min), because then the peak height is too small and retention time too long. On the other hand, it does not make much sense to increase the carrier gas flow beyond u = 30 ml/nun, because this does not result in a substantial reduction of the retention time, but in a considerable loss of sensitivity. Figure 2 shows that the optimal carrier gas flow for highest sensitivity and shortest retention time is 30 ml/min. Another variable to be optimized is the column temperature. With increasing column temperature, peak heights are elevated and retention times shortened ( fig. 3) , thereby leading to an improved sensitivity and increased analytical capacity. If the full sensitivity of the Chromatographie system is used the perazine All values are means fiom 3-10 single measurements. peak comes within the tailing of the solvent peak (at column temp. > 250°C); electronic integration techniques are, therefore, not recommended. The quantitative evaluation should be done by comparison of the peak heights with those of an internal standard.
Reproducibility
Once the optimal values for the carrier gas flow and the column temperature have been determined, their daily control is essential for routine analytical work. This can be best achieved by setting up a calibration curve before every course of analysis. 29, 59, and 118 nmol (= 10, 20, or 40 μg, resp.) perazine were used with 48.46 nmol/1 stigmasterol as internal standard (fig. 4) . The evaluation by comparison of the peak heights does not give a linear calibration curve in all cases. The correct ratio between perazine and stigmasterol concentration in the solvent must be carefully checked. Evaporation of the solvent leads to a higher concentration and thereby to changes of the peak height ratio which may result into evaluation errors. Figure 5 shows the decrease of the peak height ratios with increasing concentration of perazine and stigmasterol in the ethanolic solution (at always the same concentration ratio 1:1). Therefore, extracts which have been taken up with the standard solution should be kept cool (0-4°C) and analysed the same day.
The recovery and the analytical error of analyses obtained with perazine-spiked blank sera can be seen from between the double determination was 17.38 nmol/1 corresponding to a ratio of 0.065 between mean difference and mean value (tab. 4). The precision within one day was determined as VK = 2.55 % (N = 6; =s 364.3 nmol/1; different extractions of one pooled sample). Relative retention time was 0.59.
Specificity
The retention time of the following psychotropic compounds were determined and it was found that they do not interfere with the perazine measurement: butap erazine, trifluoperazine, levömepromazine, chlorpromazine, haloperidol, imipramine, arnitriptyline, nortryptiline. examined by analysing the same serum samples twice, i.e. 14 samples which were split immediately after collecting the blood and processed independently of each other within an interval of 5-8 days. The mean difference
Concluding remarks
The lowest detection limit of the method as described above is appr. 60 nmol/1. A clinical study which should demonstrate the practicability of the method under routine conditions, i.e. in perazine treated out-patients, has just been finished (6) . Two main metabolites, desmethylperazine and perazine sulfoxide cannot be determined together with perazine in human sera. Perazine, desmethylperazine, and perazine sulfoxide are well separated from each other by this GLC procedure; however, the retention time of desmethylperazine is the same as that of a serum lipid peak, and the sensitivity of the system for the sulfoxide is about 6 times lower than for perazine.
An independent GLC method for the determination of perazine in body fluids is thus available, in addition to the TLC method quoted above, thus providing the prerequisite for a systematic comparative control of these two clinical methods. Such internal comparative control by two independent methods appears to us much more relevant than the quality control by multicentered studies, which may result in a better comparability of the results of different laboratories, but which cannot exclude systematic analytical errors in the case of methods not yet standardized. The comparative study ofRichens (7) provides much evidence for this argument.
As the determination of neuroleptics or antidepressant drugs in human sera requires at least a 100 times higher analytical sensitivity than in the case of anticonvulsant drugs, a rigid and comparative control of the methods is essential.
